Amantadine for Dogs: Dosage by Weight, Chronic Pain, Arthritis & Safety

Amantadine is a prescription medicine veterinarians may add to a dog’s pain-management plan when chronic pain has become harder to control, particularly when central sensitization or “wind-up” is suspected. It is not usually a stand-alone painkiller. Its value is as an adjunct: a medicine that can make a multimodal plan work better when an NSAID, rehabilitation, weight control or another analgesic is not providing enough relief by itself.

Dog Medication Math Calculator

Enter your dog’s current body weight, then use only the dose already provided by your veterinarian or pharmacy label. The calculator converts lb/kg and can work out mg and liquid mL. It does not choose or recommend a dose.

Dose information from your veterinarian

Optional liquid conversion

Use the exact concentration printed on the current bottle. Different refills can have different strengths.
Safety check: This tool performs arithmetic only. It does not decide whether a drug is appropriate, choose a dose, frequency or duration, or replace a veterinarian. If the entered dose or concentration does not exactly match the prescription, stop and verify it before giving medication. See Dog Weight Converter and Dog Liquid Medication mg-to-mL Calculator.
Veterinarian assessing a dog with chronic pain before adding amantadine to a multimodal treatment plan
Amantadine is generally used as part of a broader chronic-pain strategy rather than as a replacement for diagnosis, rehabilitation or first-line analgesia.

Amantadine was originally developed as an antiviral and has also been used in human neurologic medicine, but veterinary pain specialists use its NMDA-receptor effects to address chronic pain pathways. That background can make the drug seem unusual to owners who expect every pain medicine to be an NSAID or opioid. This guide explains why it can be useful, where the evidence is strongest, what “central sensitization” means in practical terms, and what owners should watch for when a veterinarian adds amantadine to an existing plan.

What amantadine does

Amantadine is a weak N-methyl-D-aspartate, or NMDA, receptor antagonist. NMDA receptors are involved in the way the nervous system amplifies and maintains chronic pain. When pain signals continue for a long time, the spinal cord and brain can become more responsive to them. This process is often described as central sensitization or wind-up.

In that situation, the dog’s pain is not explained only by what is happening in the joint, spine or injured tissue at that moment. The nervous system itself has become part of the problem. Amantadine is used because NMDA-receptor antagonism may reduce this amplification.

Why amantadine is usually an add-on rather than a first-line drug

Merck Veterinary Manual notes that amantadine is not an effective analgesic when used alone and appears most useful in chronic neuropathic pain or pain states involving hyperalgesia and allodynia. That makes it different from an NSAID, which directly targets inflammatory pathways and is often central to canine osteoarthritis treatment when appropriate.

Think of amantadine as one piece of a layered plan. A dog with osteoarthritis may also need an NSAID, weight reduction, controlled exercise, physical rehabilitation, environmental changes, joint-support strategies or another pain-modifying drug. The veterinarian adds or removes components according to response and tolerance.

What central sensitization looks like in real life

Owners may notice that a dog reacts strongly to handling that used to be tolerated, struggles more than expected on certain surfaces, has pain that seems out of proportion to a mild touch, or remains painful even after the original injury has healed as much as expected. These observations do not prove central sensitization, but they can prompt the veterinarian to consider whether the nervous system is contributing to persistent pain.

Chronic pain also changes behavior. A dog may stop climbing stairs, hesitate before jumping into the car, avoid slippery floors, sleep more, become irritable when touched or lose interest in walks. These changes can be gradual and are sometimes mistaken for normal aging.

Osteoarthritis is a common reason amantadine enters the conversation

Canine osteoarthritis is a chronic, progressive disease. Inflammation inside the joint is only part of the experience. Over time, repeated pain signaling can alter how the nervous system processes discomfort. That is why dogs with long-standing arthritis may benefit from multimodal treatment rather than relying on a single medication.

Veterinary literature includes a clinical study in which dogs with NSAID-refractory osteoarthritis showed improved activity when amantadine was added to meloxicam. The evidence base is not as large as it is for approved canine NSAIDs, so amantadine should not be portrayed as a miracle arthritis treatment. It is better understood as a reasonable adjunct in selected dogs whose pain remains incompletely controlled.

For the broader disease picture, see Arthritis in Dogs.

Neuropathic pain and nerve-related pain states

Amantadine may also be considered when pain has a neuropathic component. Nerve injury, spinal disease, chronic compression or other neurologic conditions can produce burning, hypersensitive or difficult-to-localize pain that does not respond fully to a simple anti-inflammatory approach.

Gabapentin or pregabalin may also be used in these situations. The drugs work through different mechanisms and may be combined when the veterinarian believes the expected benefit outweighs the added complexity and side-effect risk.

Amantadine versus gabapentin

These medicines are often mentioned together, but they are not interchangeable. Gabapentin affects calcium-channel signaling and is commonly used for neuropathic pain and as part of multimodal analgesia. Amantadine acts primarily through NMDA-receptor antagonism.

One dog may respond well to gabapentin alone. Another may become too sedated on higher gabapentin doses, leading the veterinarian to consider whether another mechanism could be added instead of simply increasing one drug. A third dog may receive both because the pain is complex and several pathways appear to be involved.

See Gabapentin for Dogs for the separate drug-specific guide.

Amantadine and NSAIDs

Amantadine is often discussed as an adjunct to an NSAID in chronic osteoarthritis pain. This can make sense because the drugs act differently: the NSAID reduces inflammatory prostaglandin activity, while amantadine targets central pain amplification.

That does not make the combination automatically safe for every dog. The NSAID still requires its own screening and monitoring for kidney, liver and gastrointestinal risk. Amantadine does not “protect” the dog from NSAID adverse effects and should not be used to justify continuing an NSAID in a dog that is developing black stool, repeated vomiting or kidney problems.

Why pain assessment should come before another medication

If a dog’s mobility suddenly worsens, do not assume chronic arthritis simply needs another drug. A cruciate ligament tear, spinal disc problem, bone tumor, fracture, paw injury or neurologic disease can look like an arthritis flare. Sudden severe pain deserves examination.

Similarly, a dog that becomes weak or reluctant to walk may have anemia, heart disease, endocrine disease or neurologic dysfunction rather than increased pain. Adding medication without reassessment can delay the correct diagnosis.

What owners should tell the veterinarian first

Provide a complete list of medications and supplements, including NSAIDs, gabapentin, pregabalin, tramadol, opioids, seizure medications, behavior drugs, diuretics and urinary medications. Also mention kidney disease, liver disease, congestive heart failure, seizures, glaucoma, pregnancy or nursing status.

Amantadine is cleared largely through the kidneys. Renal disease can therefore prolong its effects and increase exposure. A dog with known kidney impairment may need a different plan or closer monitoring.

Why kidney function matters so much

Veterinary pharmacology references note that most amantadine is excreted unchanged in the urine. That makes kidney function especially relevant. Senior dogs are more likely to have chronic kidney disease, sometimes before obvious symptoms develop.

When amantadine is being considered for an older arthritic dog, the veterinarian may review recent bloodwork, urine testing and hydration status. This also helps evaluate the safety of other pain medications already in the plan.

Amantadine dosage by weight: chronic-pain reference

Current Merck osteoarthritis guidance lists amantadine at 3–5 mg/kg by mouth every 12–24 hours as an adjunctive option for dogs with moderate to severe chronic pain. Merck also emphasizes that amantadine is not a strong stand-alone analgesic; it is used to target central sensitization as part of a multimodal plan.

Reference contextPublished canine rangeMeaning
Chronic OA / pain-modifying adjunct3–5 mg/kg PO every 12–24 hoursUsually added to another pain plan rather than used alone.
Kidney diseaseNo universal adjustment chartRenal clearance means the veterinarian may need a different schedule.

See the Merck Veterinary Manual osteoarthritis guidance. If a veterinarian has already supplied a confirmed mg/kg instruction, DogMedsHub’s Dog Medication Dosage Calculator can verify arithmetic without deciding whether amantadine should be added.

Possible side effects

Veterinary information on adverse effects in dogs is more limited than for many long-established canine drugs. Reported or possible effects include agitation, soft stool, diarrhea and gas. At excessive exposure, tremors, anxiety, incoordination, dry mouth and vomiting have been described.

Because chronic-pain patients are often taking several centrally acting medications, it can be difficult to know which drug is causing a behavior or coordination change. That is why changing one element at a time, when clinically possible, can make the response easier to interpret.

Agitation versus improved energy

A dog that feels less pain may naturally become more active. That is good. Agitation is different: pacing without settling, appearing unusually anxious, restless behavior that does not match the environment, tremor or disorganized movement should be reported.

Owners should look at the whole dog rather than assuming every increase in activity proves that the treatment is working.

Why seizure history deserves attention

Veterinary guidance recommends caution in animals with seizure disorders. If the dog has epilepsy, previous unexplained seizures or is taking anticonvulsants, tell the veterinarian before starting amantadine.

A new seizure, severe tremor, collapse or marked incoordination requires urgent assessment.

How amantadine is given

Amantadine is available in oral formulations. Veterinarians use it extra-label in dogs for chronic pain. Follow the pharmacy label exactly because the appropriate schedule depends on the dog, kidney function, other medications and the treatment goal.

DogMedsHub does not provide an autonomous amantadine dose calculator. Chronic-pain treatment is not a weight-only decision. The veterinarian needs to know what type of pain is present, whether kidney disease exists, what other medications are being used and whether the dog is actually improving.

Why compounded liquids require extra attention

Some dogs need a compounded liquid because available capsule or tablet sizes are not convenient. If so, check the concentration on every refill and use an oral syringe. Compounded formulations can vary in strength and stability.

Do not assume that a previously used milliliter amount is correct after switching pharmacies or receiving a new bottle.

How quickly should owners expect a difference?

Amantadine is not usually judged by a dramatic change after a single dose. Some improvement may become noticeable over days, while fuller benefit can take longer. This is one reason a structured mobility log is useful.

Ask the veterinarian when they want the response reassessed. If no meaningful improvement appears by the expected review point, the plan may need to change.

What “working” should look like

Better pain control is not simply a sleepy dog that moves less. Useful outcomes include easier rising, more willingness to walk, smoother transitions on stairs, improved sleep, greater interest in normal activities and less pain when moving through everyday tasks.

Video can be helpful. Record the dog rising from bed, walking across the same floor, using steps or getting into the car before treatment and again at follow-up. Small improvements are easier to see side by side than from memory.

Why weight management still matters

No pain medication can fully compensate for excess mechanical load on arthritic joints. Even modest weight reduction can improve mobility in overweight dogs and may allow the veterinarian to use a safer, simpler medication plan.

Weight loss should be gradual and based on a feeding plan that preserves lean muscle. Severe calorie restriction can worsen weakness and make mobility look poorer even when the joints are less loaded.

Rehabilitation and home changes

Physical rehabilitation, controlled strengthening and appropriate low-impact exercise can improve function in many chronic-pain patients. The exact program depends on the diagnosis. Too much exercise during a flare can worsen pain, while prolonged inactivity can lead to muscle loss and instability.

At home, nonslip rugs, ramps, supportive bedding, trimmed nails and avoiding repeated jumping can reduce daily strain. These changes are not “less important” because they are not medications. For many senior dogs they make a meaningful difference.

What if a dose is missed?

Do not double the next dose unless the veterinarian tells you to. If the missed dose is noticed close to the next scheduled time, the usual approach may be to skip it and return to the regular schedule.

See Missed Dog Medication Dose for general safety guidance.

What if an extra dose is given?

Call with the product strength, amount, time and dog’s weight. Extra exposure may increase agitation, tremors, anxiety, vomiting or incoordination. Kidney disease can prolong effects, so mention it immediately if present.

For general preparation before the call, see Dog Got a Double Dose of Medication.

Why frequent medication changes can confuse the picture

Chronic-pain plans often involve several treatments at once. If the NSAID is changed, gabapentin is increased, amantadine is started and exercise is reduced all in the same week, it becomes difficult to know which change helped or harmed the dog.

Sometimes multiple changes are medically necessary, especially when pain is severe. When there is time, however, a staged approach with documented goals can produce clearer information.

When amantadine should be reconsidered

Every chronic medication should have a reason to continue. If the dog shows no functional improvement after an appropriate trial, the veterinarian may decide the benefit is too small. If side effects outweigh gains, the plan should also be revisited.

Conversely, a dog that improves should still have periodic pain reassessment because osteoarthritis and other chronic diseases change over time. The medication that works this year may not be the whole answer next year.

A realistic scenario: the older dog who is still painful on an NSAID

Imagine a senior Labrador with documented hip and knee osteoarthritis. The dog is at a healthy weight, kidney and liver screening are acceptable, and an NSAID has reduced stiffness but the dog still struggles to rise after resting and avoids longer walks. Examination does not suggest a new orthopedic injury. The veterinarian believes central sensitization is contributing to persistent pain and adds amantadine as part of the existing plan.

The owner tracks rising, stair use and walk duration over the next several weeks. Improvement is judged by function, not by whether the dog seems sedated. That is the kind of situation in which an adjunctive pain-modifying drug can make sense.

A different scenario: sudden worsening should not be treated as “more arthritis”

Now imagine the same dog suddenly refuses to bear weight on one hind leg after slipping in the yard. Adding more chronic-pain medication without examination could miss a cruciate injury, fracture or other acute problem. Chronic pain history does not make every new pain episode chronic.

When to call the veterinarian

Contact the clinic for persistent agitation, diarrhea, vomiting, loss of appetite, new weakness, worsening incoordination, tremors or lack of meaningful pain improvement. Also call if the dog’s mobility changes suddenly rather than gradually.

When urgent care is appropriate

Seek urgent assessment for seizures, collapse, severe tremors, inability to stand, suspected large overdose, sudden paralysis or severe uncontrolled pain.

What owners should track

  • time each dose is given;
  • ability to rise from rest;
  • willingness to walk and climb steps;
  • sleep quality;
  • touch sensitivity and irritability;
  • stool quality and appetite;
  • agitation, tremor or incoordination;
  • other pain medicines given the same day.

Questions worth asking the veterinarian

  • What type of pain do you think amantadine is targeting?
  • Is it being added to an NSAID, gabapentin or another analgesic?
  • Does my dog need kidney testing before or during treatment?
  • What functional change would count as a successful response?
  • How long should we trial it before deciding whether it helps?
  • Which side effects should make me stop and call?
  • Could a sudden mobility change indicate a new injury instead of an arthritis flare?

How this page fits DogMedsHub

This is DogMedsHub’s main medication guide for amantadine. The Pain & Anti-inflammatory Medicines hub explains the larger medication landscape, while Arthritis in Dogs covers diagnosis, monitoring and long-term disease management. This page stays focused on amantadine’s role in central sensitization and multimodal pain treatment.

Sources and review notes

The Merck Veterinary Manual review of analgesics used in animals describes amantadine as an NMDA-receptor antagonist that is most useful as an adjunct for chronic neuropathic pain and notes clinical improvement when it was added to meloxicam in dogs with NSAID-refractory osteoarthritis. Merck’s osteoarthritis guidance also lists amantadine among pain-modifying options for dogs with more advanced clinical signs. VCA medication guidance notes possible agitation and gastrointestinal effects and recommends caution in kidney disease and seizure disorders.

Last reviewed: October 2026. DogMedsHub provides source-backed canine medication guidance. This page does not diagnose chronic pain, replace a veterinary examination or provide an individualized amantadine dose.

Share